Form 4 for EGAN EGAIN Corp
Accepted 2025-10-07 00:00:00 ET · period of report 2025-10-03 · accession 0001259393-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-07 | 2025-10-03 | EGAN | SMIT ERIC | CFO | S - Sale+OE | $10.00 | -15.0K | 129.2K | -10% | -$150.0K |
| DM | 2025-10-07 | 2025-10-03 | EGAN | SMIT ERIC | CFO | M - OptEx | $2.50 | +15.0K | 144.2K | +12% | +$37.5K |
| DM | 2025-10-07 | 2025-10-03 | EGAN | SMIT ERIC | CFO | M - OptEx | $0.00 | -15.0K | 48.0K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-03 | S | D | 5,000 | $10.00 | 139,187 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. |
| 2 | Common | Common Stock | 2025-10-03 | S | D | 5,000 | $10.00 | 134,187 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. |
| 3 | Common | Common Stock | 2025-10-03 | S | D | 5,000 | $10.00 | 129,187 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. |
| 4 | Common | Common Stock | 2025-10-03 | M | A | 5,000 | $2.50 | 139,187 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. |
| 5 | Common | Common Stock | 2025-10-03 | M | A | 5,000 | $2.50 | 134,187 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. |
| 6 | Common | Common Stock | 2025-10-03 | M | A | 5,000 | $2.50 | 144,187 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 8, 2024. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2025-10-03 | M | D | 5,000 | $0.00 | 53,000 | D | $2.50 · — to 2027-09-19 | 5,000 Common Stock | (F2) The options, representing a right to purchase a total of 112,000 shares, became exercisable beginning on September 19, 2017, and is now fully vested. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2025-10-03 | M | D | 5,000 | $0.00 | 43,000 | D | $2.50 · — to 2027-09-19 | 5,000 Common Stock | (F2) The options, representing a right to purchase a total of 112,000 shares, became exercisable beginning on September 19, 2017, and is now fully vested. |
| 9 | Derivative | Employee Stock Option (right to buy) | 2025-10-03 | M | D | 5,000 | $0.00 | 48,000 | D | $2.50 · — to 2027-09-19 | 5,000 Common Stock | (F2) The options, representing a right to purchase a total of 112,000 shares, became exercisable beginning on September 19, 2017, and is now fully vested. |